10.1159/000430398 182 XieW.WangL.ShengH.QiuJ.ZhangD.ZhangL.et al (2017)
Outcome measurements
Key cautions to keep in view Research status and evidence limits: Much of the mechanistic work is preclinical, and human data are limited
Microdosing potential: Lower or slower dosing may reduce nausea, appetite suppression, muscle loss, and other side effects for some patients, though this should be medically supervised
161 Over a period of 24 weeks, all dosage groups of retatrutide showed significant improvements in reducing glycated hemoglobin (HbA1c) and body weight compared to the placebo group, especially in the higher dosage groups
Complete PCOS Treatment Approach Oana Health goes beyond weight management by combining GLP-1 medications with Metformin to address insulin resistance, hormonal imbalances, and other PCOS symptoms